Vincent Brichard
InvestorVenture Partner at EQT Life Sciences
Brussels
Writes $1M – $5M checks · typically $1.5M
About
Vincent Brichard is a Venture Partner at EQT Group, a European venture capital firm focused on biotechnology. With over a decade of professional experience, he specializes in clinical trials, oncology, and research and development strategy, supporting portfolio companies in clinical development and strategic initiatives.
Contact· self-published, not guessed
Experience
- EQT GroupVenture Partnercurrent2015 — present
- VIANOVA srlFounder & CEOcurrent2014 — present
- Solvay Lifelong Learning | Solvay Brussels School of Economics & ManagementProfessor Advanced Master in Biotechnology - Solvaycurrent2022 — present
- Fournier-Majoie FoundationScientific & Investment Advisory Boardcurrent2015 — present
- atbtherapeuticsIndependent Board member2018 — 2024
- ethernaIndependent Board member2016 — 2022
- PARACRINE THERAPEUTICSCo-founder&CEO2019 — 2020
- ChromaCureChairman of the Board2018 — 2020
- Celyad OncologyVice-President Oncology2014 — 2015
- GlaxoSmithKline BiologicalsSenior Executive Vice President2002 — 2014GlaxoSmithKline Biologicals
- Harvard Business SchoolMBA2012
- Université catholique de LouvainProfessor of Oncology2000 — 2002
- Institut CurieMedical Oncology Department1998 — 2000
- Ludwig Cancer ResearchPHD1990 — 1996
Skills & more
Clinical Trials31Oncology61Biotechnology29Infectious Diseases14Vaccines29Immunology41Medicine18Clinical Development12Life Sciences13Market Access8Drug Development9Diabetes1
+2 more
BiopharmaceuticalsDrug DiscoveryLanguages English · French
From Vincent's professional profile.
Colleagues at EQT Life Sciences
Alex Darden
Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures
Alexandra Edlund
Chief People Officer at EQT Life Sciences
Anne Portwich
Partner at EQT Life Sciences
Arno de Wilde
Investor at EQT Life Sciences
Bert Janssens
Partner, Co-Head of Private Capital at EQT Life Sciences
Bruno Holthof
Partner at EQT Life Sciences
Chris Stone
Investor at EPIC VENTURES
Christina Drews
Chief Operating Officer at EQT Life Sciences
Frequently asked questions
- Who is Vincent Brichard?
- Vincent Brichard is a Venture Partner at EQT Group, a European venture capital firm focused on biotechnology. With over a decade of professional experience, he specializes in clinical trials, oncology, and research and development strategy, supporting portfolio companies in clinical development and strategic initiatives.
- Where does Vincent Brichard work?
- Vincent Brichard is Venture Partner at EQT Life Sciences.
- What check size does Vincent Brichard write?
- Vincent Brichard typically writes checks of $1M – $5M.
- Where did Vincent Brichard go to school?
- Vincent Brichard studied at Université catholique de Louvain (MD, oncology).
Same school
Also attended Université catholique de Louvain59
Thomas DelplanqueRegulatory Director at Hummingbird VenturesIñigo López-HuertaCFO at Ysios CapitalCharles de LiedekerkeInvestor at Inventures Investment PartnersPaul VarassoPrincipal at Axeleo CapitalJérôme WittamerCo-founder and Managing Partner at Expon CapitalYves TrouveroyInvestment Partner at E-Capital Equity Management
+ 53 more
Shared employers
Also worked at Solvay Lifelong Learning | Solvay Brussels School of Economics & Management2
Also worked at etherna3
Also worked at GlaxoSmithKline Biologicals116
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 110 more
Also worked at Institut Curie9
Elena BattistelloAnalyst at Novartis Venture FundCatherine BouleManaging Partner at KaristaAlexandra GylfeFounding Partner at Nordic Science InvestmentsAlena IvashenkaLife Sciences Investor at Venture Capital World SummitLouise-Marie RakotoarisonAnalyst at Kurma PartnersClaire CatherinetSenior Associate, Crossover Strategy at Sofinnova Partners
+ 3 more










































